Charles D Imbusch

12PUBLICATIONS
103CO-AUTHORS
Haematological tumoursChemical and thermal processes in energy and combustionEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 05, 2026
APOBEC2 deficiency disrupts hematopoietic lineage commitment, resulting in emergence of dual identity lymphocytes in mice and humans.

|Feb 23, 2026
Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.

Maria Llamazares-Prada, Uwe Schwartz, Darius F Pease

|Jul 16, 2025
DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterparts.

Niklas Beumer, Charles D Imbusch, Tamara Kaufmann

|Mar 24, 2025
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial.

Sonja Loges, Michael Heuser, Jörg Chromik

|Nov 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.

Raphael Lutz, Florian Grünschläger, Malte Simon

|Sep 16, 2024
SOX10 mediates glioblastoma cell-state plasticity.

Ka-Hou Man, Yonghe Wu, Zhenjiang Gao

Pageof 2

Frequent Collaborators

4 joint publications

Benedikt Brors

3 joint publications

Michael Delacher

3 joint publications

Michael Rehli

3 joint publications

Markus Feuerer